88 related articles for article (PubMed ID: 21254089)
1. An early diagnostic tool for diabetic neuropathy: conduction velocity distribution.
Tuncer S; Dalkilic N; Esen HH; Avunduk MC
Muscle Nerve; 2011 Feb; 43(2):237-44. PubMed ID: 21254089
[TBL] [Abstract][Full Text] [Related]
2. Conduction velocity distribution: early diagnostic tool for peripheral neuropathies.
Kiziltan E; Dalkilic N; Guney FB; Pehlivan F
Int J Neurosci; 2007 Feb; 117(2):203-13. PubMed ID: 17365108
[TBL] [Abstract][Full Text] [Related]
3. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
Biessels GJ; ter Laak MP; Kamal A; Gispen WH
Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
[TBL] [Abstract][Full Text] [Related]
4. Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions.
Ayaz M; Tuncer S; Okudan N; Gokbel H
Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):367-74. PubMed ID: 18806896
[TBL] [Abstract][Full Text] [Related]
5. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy.
Wang Y; Schmelzer JD; Schmeichel A; Iida H; Low PA
J Neurol Sci; 2004 Dec; 227(1):101-7. PubMed ID: 15546599
[TBL] [Abstract][Full Text] [Related]
7. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes.
Yagihashi S; Wada R; Kamijo M; Nagai K
Lab Invest; 1993 Mar; 68(3):296-307. PubMed ID: 8383778
[TBL] [Abstract][Full Text] [Related]
8. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.
Negi G; Kumar A; Kaundal RK; Gulati A; Sharma SS
Neuropharmacology; 2010 Mar; 58(3):585-92. PubMed ID: 20005237
[TBL] [Abstract][Full Text] [Related]
10. Hyperosmolar solutions selectively block action potentials in rat myelinated sensory fibers: implications for diabetic neuropathy.
Matsuka Y; Spigelman I
J Neurophysiol; 2004 Jan; 91(1):48-56. PubMed ID: 13679399
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
[TBL] [Abstract][Full Text] [Related]
12. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats.
Rodrigues Filho OA; Fazan VP
J Neurosci Methods; 2006 Mar; 151(2):131-8. PubMed ID: 16125783
[TBL] [Abstract][Full Text] [Related]
13. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
14. Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat.
Spüler M; Dimpfel W; Tüllner HU
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):211-23. PubMed ID: 3307667
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin provides protection against diabetic polyneuropathy in rats.
Erbas O; Taşkıran D; Oltulu F; Yavaşoğlu A; Bora S; Bilge O; Çınar BP; Peker G
Neurol Res; 2017 Jan; 39(1):45-53. PubMed ID: 27881053
[TBL] [Abstract][Full Text] [Related]
16. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.
Serafín A; Molín J; Márquez M; Blasco E; Vidal E; Foradada L; Añor S; Rabanal RM; Fondevila D; Bosch F; Pumarola M
Muscle Nerve; 2010 May; 41(5):630-41. PubMed ID: 19918773
[TBL] [Abstract][Full Text] [Related]
17. An experimental model of an electrical injury to the peripheral nerve.
Fan KW; Zhu ZX; Den ZY
Burns; 2005 Sep; 31(6):731-6. PubMed ID: 16129227
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
19. Role of A3 adenosine receptor in diabetic neuropathy.
Yan H; Zhang E; Feng C; Zhao X
J Neurosci Res; 2016 Oct; 94(10):936-46. PubMed ID: 27319979
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma levels of adrenomedullin and ghrelin, and their correlation with electrophysiological changes in diabetic neuropathy.
Zakareia FA
Neurosciences (Riyadh); 2012 Oct; 17(4):327-35. PubMed ID: 23022897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
